Google Play mobile download button
Apple IOS mobile download button
Google Play mobile download button
Apple IOS mobile download button
HomeBusinessMerck, Sichuan Kelun enter cancer collaboration, with milestone payments up to $9.3...

Balanced News: Merck, Sichuan Kelun enter cancer collaboration, with milestone payments up to $9.3 billion

Our 'quick read' news summary

Merck & Co. Inc. MRK, +0.12% said Thursday that it entered into an agreement with Sichuan Kelun Pharmaceutical Co. Ltd. 002422, +10.00% to develop seven new cancer therapies. Merck will pay the Chinse biotech an upfront payment of $175 million, with milestone payments worth up to $9.3 billion. Merck will also make an equity investment in the company.

Read different perspectives from these news sources

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

More top reads from Balanced News Summary

Do you agree with this post's rating?
0
(0)
- Advertisment -
- Advertisment -